| Andrew Lee Sorenson, MD | |
|
3010 Colby St, Ste 114, Berkeley, CA 94705-2059 | |
| (510) 848-1413 | |
| (510) 848-7347 |
| Full Name | Andrew Lee Sorenson |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 29 Years |
| Location | 3010 Colby St, Berkeley, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326139981 | NPI | - | NPPES |
| G815550 | Other | CA | STATE MEDICAL LICENSE |
| GR0021950 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | G66123 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alta Bates Summit Medical Center - Alta Bates Camp | Berkeley, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sorenson And Sorenson Md Inc | 2668411851 | 5 |
News Archive
The research team uses a genetically modified mouse that produces a muted and constantly active CAAX protein. This is a new model for an extremely aggressive lung cancer and a mild form of blood cancer. In these mice, the production of an enzyme called GGTas1 can also be stopped.
A team of researchers from the CNRS and Université Nice Sophia Antipolis has just shown that a small molecule called methiothepin can inhibit the chemotherapy resistance of certain tumors.
In an effort to counter the public's growing skepticism over health reform, "supporters of President Barack Obama's health care agenda are ramping up their efforts with rallies and bus tours starting this week," the Associated Press reports.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2014.
› Verified 4 days ago
| Entity Name | Sorenson & Sorenson Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215067749 PECOS PAC ID: 2668411851 Enrollment ID: O20050427000755 |
News Archive
The research team uses a genetically modified mouse that produces a muted and constantly active CAAX protein. This is a new model for an extremely aggressive lung cancer and a mild form of blood cancer. In these mice, the production of an enzyme called GGTas1 can also be stopped.
A team of researchers from the CNRS and Université Nice Sophia Antipolis has just shown that a small molecule called methiothepin can inhibit the chemotherapy resistance of certain tumors.
In an effort to counter the public's growing skepticism over health reform, "supporters of President Barack Obama's health care agenda are ramping up their efforts with rallies and bus tours starting this week," the Associated Press reports.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2014.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Lee Sorenson, MD 3010 Colby St, Ste 114, Berkeley, CA 94705-2059 Ph: (510) 848-1413 | Andrew Lee Sorenson, MD 3010 Colby St, Ste 114, Berkeley, CA 94705-2059 Ph: (510) 848-1413 |
News Archive
The research team uses a genetically modified mouse that produces a muted and constantly active CAAX protein. This is a new model for an extremely aggressive lung cancer and a mild form of blood cancer. In these mice, the production of an enzyme called GGTas1 can also be stopped.
A team of researchers from the CNRS and Université Nice Sophia Antipolis has just shown that a small molecule called methiothepin can inhibit the chemotherapy resistance of certain tumors.
In an effort to counter the public's growing skepticism over health reform, "supporters of President Barack Obama's health care agenda are ramping up their efforts with rallies and bus tours starting this week," the Associated Press reports.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2014.
› Verified 4 days ago
Lionel Winton Sorenson, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3010 Colby St, Ste 114, Berkeley, CA 94705 Phone: 510-848-1413 Fax: 510-848-7347 | |
Dr. Melissa Neuwelt, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3100 San Pablo Ave, Berkeley, CA 94702 Phone: 510-985-5100 | |
Dr. Myron Lee, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3000 Colby St, Suite 104, Berkeley, CA 94705 Phone: 510-843-4613 Fax: 510-843-4652 | |
John Gilman, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1714 Madera St, Berkeley, CA 94707 Phone: 916-616-4788 | |
Robert Lynn Sorenson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3010 Colby St, Ste 114, Berkeley, CA 94705 Phone: 510-848-1413 Fax: 510-848-7347 | |
Rebecca Sorenson Janik, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3010 Colby St, Suite 114, Berkeley, CA 94705 Phone: 510-848-1413 |